Search research articles
Contact Us
Filters
Showing results (11-20 of 25) with videos related to
Page
of 3
Sort By:
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
September 9, 2017
Pulmonary large cell neuroendocrine carcinoma with adenocarcinoma-like features: napsin A expression and genomic alterations
Natasha Rekhtman, Catherine M Pietanza, Joshua Sabari, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
November 4, 2017
BRMS1 Expression in Surgically Resected Lung Adenocarcinoma Predicts Future Metastases and Is Associated with a Poor Prognosis
Peter R Bucciarelli, Kay See Tan, Neel P Chudgar, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
September 24, 2018
Lobectomy Is Associated with Better Outcomes than Sublobar Resection in Spread through Air Spaces (STAS)-Positive T1 Lung Adenocarcinoma: A Propensity Score-Matched Analysis
Takashi Eguchi, Koji Kameda, Shaohua Lu, et al.
The Lancet. Oncology
|
November 10, 2016
Cabozantinib in patients with advanced RET-rearranged non-small-cell lung cancer: an open-label, single-centre, phase 2, single-arm trial
Alexander Drilon, Natasha Rekhtman, Maria Arcila, et al.
The American Journal of Surgical Pathology
|
May 31, 2018
Bronchiolar Adenoma: Expansion of the Concept of Ciliated Muconodular Papillary Tumors With Proposal for Revised Terminology Based on Morphologic, Immunophenotypic, and Genomic Analysis of 25 Cases
Jason C Chang, Joseph Montecalvo, Laetitia Borsu, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
November 13, 2018
Outcomes after neoadjuvant or adjuvant chemotherapy for cT2-4N0-1 non-small cell lung cancer: A propensity-matched analysis
Whitney S Brandt, Wanpu Yan, Jian Zhou, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
March 30, 2019
Stage IV lung carcinoids: spectrum and evolution of proliferation rate, focusing on variants with elevated proliferation indices
Natasha Rekhtman, Patrice Desmeules, Anna M Litvak, et al.
Cold Spring Harbor Molecular Case Studies
|
April 3, 2019
Exceptional responders with invasive mucinous adenocarcinomas: a phase 2 trial of bortezomib in patients with <i>KRAS</i> G12D-mutant lung cancers
Alexander Drilon, Adam J Schoenfeld, Kathryn C Arbour, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
October 4, 2020
SCLC Subtypes Defined by ASCL1, NEUROD1, POU2F3, and YAP1: A Comprehensive Immunohistochemical and Histopathologic Characterization
Marina K Baine, Min-Shu Hsieh, W Victoria Lai, et al.
JCO Precision Oncology
|
June 14, 2019
Immunophenotype and Response to Immunotherapy of RET-Rearranged Lung Cancers
Michael Offin, Robin Guo, Stephanie L Wu, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 25) with videos related to
Sort By:
Page
of 3
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
September 9, 2017
Pulmonary large cell neuroendocrine carcinoma with adenocarcinoma-like features: napsin A expression and genomic alterations
Natasha Rekhtman, Catherine M Pietanza, Joshua Sabari, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
November 4, 2017
BRMS1 Expression in Surgically Resected Lung Adenocarcinoma Predicts Future Metastases and Is Associated with a Poor Prognosis
Peter R Bucciarelli, Kay See Tan, Neel P Chudgar, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
September 24, 2018
Lobectomy Is Associated with Better Outcomes than Sublobar Resection in Spread through Air Spaces (STAS)-Positive T1 Lung Adenocarcinoma: A Propensity Score-Matched Analysis
Takashi Eguchi, Koji Kameda, Shaohua Lu, et al.
The Lancet. Oncology
|
November 10, 2016
Cabozantinib in patients with advanced RET-rearranged non-small-cell lung cancer: an open-label, single-centre, phase 2, single-arm trial
Alexander Drilon, Natasha Rekhtman, Maria Arcila, et al.
The American Journal of Surgical Pathology
|
May 31, 2018
Bronchiolar Adenoma: Expansion of the Concept of Ciliated Muconodular Papillary Tumors With Proposal for Revised Terminology Based on Morphologic, Immunophenotypic, and Genomic Analysis of 25 Cases
Jason C Chang, Joseph Montecalvo, Laetitia Borsu, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
November 13, 2018
Outcomes after neoadjuvant or adjuvant chemotherapy for cT2-4N0-1 non-small cell lung cancer: A propensity-matched analysis
Whitney S Brandt, Wanpu Yan, Jian Zhou, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
March 30, 2019
Stage IV lung carcinoids: spectrum and evolution of proliferation rate, focusing on variants with elevated proliferation indices
Natasha Rekhtman, Patrice Desmeules, Anna M Litvak, et al.
Cold Spring Harbor Molecular Case Studies
|
April 3, 2019
Exceptional responders with invasive mucinous adenocarcinomas: a phase 2 trial of bortezomib in patients with <i>KRAS</i> G12D-mutant lung cancers
Alexander Drilon, Adam J Schoenfeld, Kathryn C Arbour, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
October 4, 2020
SCLC Subtypes Defined by ASCL1, NEUROD1, POU2F3, and YAP1: A Comprehensive Immunohistochemical and Histopathologic Characterization
Marina K Baine, Min-Shu Hsieh, W Victoria Lai, et al.
JCO Precision Oncology
|
June 14, 2019
Immunophenotype and Response to Immunotherapy of RET-Rearranged Lung Cancers
Michael Offin, Robin Guo, Stephanie L Wu, et al.
Page
of 3